Value Added Medicines

Executive Summary

In this section of MAP Online, we review the typology of value-added medicinal (VAM) products, outline how value can be added to existing generic medicines and discuss how health technology assessments (HTAs) should be approached. We include which HTA attributes are most important and how to capture the full value of VAMs in HTAs in order to maximise the chance of successful pricing and reimbursement. We have also included examples and case studies of existing VAM products.